Policy Advocacy in Health Economics
Expert-defined terms from the Professional Certificate in Health Economics and Market Access course at London School of Planning and Management. Free to read, free to share, paired with a professional course.
Advocacy Coalition – A group of stakeholders sharing common beliefs about… #
Related terms: Coalition building, policy network. Example: Pharmaceutical firms, patient groups, and clinicians forming a coalition to promote reimbursement for a new oncology drug. Practical application: Coordinated lobbying, joint research publications, and shared messaging. Challenges: Aligning diverse interests, managing conflicts of interest, and sustaining long‑term engagement.
Advocacy Strategy – A systematic plan outlining objectives, target audien… #
Related terms: Strategic planning, communication plan. Example: A stepwise approach to secure inclusion of a rare disease therapy in national formularies. Practical application: Setting measurable milestones, selecting appropriate media, and allocating resources. Challenges: Adapting to evolving political landscapes, measuring impact, and ensuring stakeholder buy‑in.
Benefit‑Risk Assessment – Evaluation of the therapeutic advantages of a h… #
Related terms: Health technology assessment, safety profile. Example: Comparing the survival benefit of a new immunotherapy against the incidence of severe immune‑related adverse events. Practical application: Informing reimbursement decisions and shaping advocacy messages. Challenges: Limited long‑term data, heterogeneity of patient populations, and differing risk tolerances among payers.
Budget Impact Analysis (BIA) – A financial model estimating the short‑ter… #
Related terms: Cost‑effectiveness analysis, payer perspective. Example: Projecting the fiscal effect of adding a high‑cost gene therapy to a national health insurance plan. Practical application: Providing evidence for policymakers to justify funding. Challenges: Data availability, assumptions about uptake rates, and variability across jurisdictions.
Capacity Building – Activities aimed at enhancing the skills, resources,… #
Related terms: Training, empowerment. Example: Workshops for patient organizations on health economics fundamentals. Practical application: Improving the quality of evidence generated and arguments presented to legislators. Challenges: Limited funding, varying baseline expertise, and sustaining momentum after training.
Clinical Guidelines – Systematically developed statements that assist pra… #
Related terms: Standard of care, evidence‑based practice. Example: Guidelines recommending first‑line use of a novel antiviral for hepatitis C. Practical application: Leveraging guideline endorsement to support market access. Challenges: Time lag between evidence emergence and guideline updates, and potential conflicts of interest in guideline development.
Collaboration Platform – Digital or physical space where multiple stakeho… #
Related terms: Stakeholder portal, knowledge hub. Example: An online repository sharing policy briefs, data visualizations, and meeting minutes. Practical application: Streamlining communication, avoiding duplication, and fostering transparency. Challenges: Data security, user adoption, and maintaining up‑to‑date content.
Cost‑Effectiveness Threshold – The maximum amount a payer is willing to s… #
G., Per quality‑adjusted life year). Related terms: Willingness‑to‑pay, incremental cost‑effectiveness ratio. Example: A $50,000 per QALY threshold used by a national health service. Practical application: Shaping advocacy arguments to demonstrate that a technology falls below the threshold. Challenges: Thresholds differ across countries, are often implicit, and may shift with budget constraints.
Cost‑Utility Analysis (CUA) – A form of economic evaluation that measures… #
G., QALYs) and compares them to costs. Related terms: Health economics, outcome measurement. Example: Assessing a new cardiac device by calculating cost per QALY gained. Practical application: Providing robust evidence for reimbursement submissions. Challenges: Assigning utility values, handling societal versus payer perspectives, and dealing with methodological heterogeneity.
Cross‑Sector Advocacy – Efforts that engage actors beyond the health syst… #
Related terms: Intersectoral collaboration, policy integration. Example: Partnering with occupational health agencies to promote workplace screening programs. Practical application: Broadening the policy agenda and creating synergistic solutions. Challenges: Differing priorities, regulatory silos, and complex coordination mechanisms.
Data Transparency – The openness of data sources, methods, and results us… #
Related terms: Open science, reproducibility. Example: Publishing raw cost data from a clinical trial to allow independent verification. Practical application: Building credibility with policymakers and the public. Challenges: Proprietary data restrictions, confidentiality concerns, and resource demands for data curation.
Decision‑Analytic Modeling – Use of mathematical models to simulate healt… #
Related terms: Markov model, simulation. Example: A lifetime model comparing a gene therapy to standard of care for a rare disease. Practical application: Projecting long‑term value for advocacy and reimbursement dossiers. Challenges: Model validation, parameter uncertainty, and stakeholder acceptance of assumptions.
Economic Burden of Disease – The total cost associated with a disease, in… #
Related terms: Cost of illness, societal cost. Example: Estimating the €2 billion annual burden of diabetes in a European country. Practical application: Highlighting the need for investment in preventive therapies. Challenges: Data gaps, attribution of costs, and regional variability.
Evidence Synthesis – Systematic aggregation of research findings to infor… #
Related terms: Literature review, pooled analysis. Example: A meta‑analysis of real‑world effectiveness of an immunotherapy across multiple cancers. Practical application: Strengthening the evidence base for advocacy messages. Challenges: Heterogeneity of studies, publication bias, and rapid evidence turnover.
External Stakeholder Engagement – Involving parties outside the organizat… #
G., Patients, NGOs, industry) in policy development processes. Related terms: Public consultation, participatory governance. Example: Inviting patient representatives to a health technology assessment committee. Practical application: Ensuring diverse perspectives shape reimbursement criteria. Challenges: Managing power imbalances, ensuring representativeness, and integrating feedback efficiently.
Formulary Management – The process by which payers select, negotiate, and… #
Related terms: Drug list, reimbursement tier. Example: A national formulary that restricts high‑cost oncology drugs to specific indications. Practical application: Advocacy efforts targeting formulary inclusion criteria. Challenges: Limited formulary slots, price negotiations, and evidence requirements.
Health Impact Assessment (HIA) – A systematic process to evaluate the pot… #
Related terms: Impact evaluation, risk assessment. Example: Assessing how a new taxation policy on sugary drinks may reduce obesity rates. Practical application: Providing quantitative arguments for policy change. Challenges: Attributing causality, time‑lag between policy and outcomes, and data availability.
Health Literacy – The capacity of individuals to obtain, process, and und… #
Related terms: Patient education, communication. Example: Simplified brochures explaining the benefits of a new vaccine. Practical application: Empowering patients to support advocacy campaigns. Challenges: Cultural differences, varying education levels, and misinformation.
Health Technology Assessment (HTA) – A multidisciplinary evaluation of th… #
Related terms: Appraisal, evidence synthesis. Example: An HTA report recommending reimbursement for a novel dialysis device. Practical application: Providing the cornerstone evidence for market access negotiations. Challenges: Long assessment timelines, divergent methodological standards, and political pressures.
Implementation Science – The study of methods to promote the uptake of re… #
Related terms: Knowledge translation, diffusion of innovation. Example: Evaluating strategies to integrate a new hypertension guideline into primary care. Practical application: Ensuring that advocacy‑driven policy changes translate into real‑world benefits. Challenges: Contextual variability, resource constraints, and measuring implementation fidelity.
Influencer Mapping – Identification and analysis of key individuals who c… #
Related terms: Stakeholder analysis, power mapping. Example: Recognizing a senior health ministry official as a champion for rare disease funding. Practical application: Targeting advocacy outreach to high‑impact actors. Challenges: Dynamic political environments, hidden influencers, and limited access.
International Reference Pricing (IRP) – A pricing strategy where a countr… #
Related terms: Price benchmarking, external price referencing. Example: Using the lowest price among OECD countries to cap the price of a new biologic. Practical application: Informing price negotiations and advocacy arguments about fairness. Challenges: Data reliability, currency fluctuations, and potential for parallel trade.
Legislative Advocacy – Direct engagement with lawmakers to shape legislat… #
Related terms: Lobbying, policy brief. Example: Drafting a bill that mandates coverage of high‑cost therapies for orphan diseases. Practical application: Influencing statutory frameworks that determine reimbursement. Challenges: Political cycles, competing legislative priorities, and the need for compelling evidence.
Market Access Strategy – A comprehensive plan to achieve optimal product… #
Related terms: Launch plan, pricing strategy. Example: A phased approach combining health economic submissions, payer negotiations, and patient‑group partnerships for a new vaccine. Practical application: Aligning advocacy activities with commercial objectives. Challenges: Regulatory heterogeneity, resource allocation, and forecasting uncertainties.
Patient‑Reported Outcome Measures (PROMs) – Instruments that capture pati… #
Related terms: Quality‑of‑life scales, health surveys. Example: Using the EQ‑5D to quantify benefits of a chronic pain medication. Practical application: Strengthening the human element of economic arguments. Challenges: Instrument selection, cultural adaptation, and data collection logistics.
Pharmacoeconomic Modeling – Construction of quantitative frameworks to as… #
Related terms: Cost‑effectiveness model, decision analysis. Example: A model projecting the budget impact of a novel anticoagulant over ten years. Practical application: Generating evidence for payer negotiations and advocacy briefs. Challenges: Parameter uncertainty, model complexity, and stakeholder acceptance.
Policy Brief – A concise, evidence‑based document designed to inform and… #
Related terms: Position paper, advocacy note. Example: A two‑page brief outlining the cost‑benefit of expanding mental health services. Practical application: Delivering key messages in an accessible format. Challenges: Balancing depth with brevity, tailoring to diverse audiences, and ensuring timely dissemination.
Policy Cycle – The sequential stages of agenda setting, formulation, adop… #
Related terms: Policy process, governance. Example: Mapping how a new vaccination policy moves from proposal to rollout. Practical application: Timing advocacy interventions to align with each phase. Challenges: Non‑linear progress, political disruptions, and feedback loops.
Price Negotiation – The process by which payers and manufacturers discuss… #
Related terms: Discount, rebate. Example: Securing a confidential discount for a high‑cost oncology drug in exchange for formulary placement. Practical application: Leveraging economic evidence to achieve favorable terms. Challenges: Information asymmetry, confidentiality constraints, and divergent valuation methods.
Real‑World Evidence (RWE) – Data on the usage and outcomes of health inte… #
Related terms: Observational data, registry. Example: Post‑marketing data showing improved survival with a targeted therapy in routine practice. Practical application: Supplementing clinical trial evidence in advocacy arguments. Challenges: Data quality, confounding bias, and regulatory acceptance.
Reimbursement Pathway – The procedural route through which a health techn… #
Related terms: Coverage decision, funding mechanism. Example: The multi‑step appraisal process for a new diabetic implant in a national health service. Practical application: Mapping critical decision points for targeted advocacy. Challenges: Varying requirements across regions, lengthy timelines, and complex documentation.
Regulatory Science – The discipline focused on developing tools, standard… #
Related terms: Drug approval, risk assessment. Example: Using adaptive trial designs to accelerate approval of a breakthrough therapy. Practical application: Informing policy discussions on regulatory flexibility. Challenges: Balancing innovation with safety, data sufficiency, and international harmonization.
Risk‑Sharing Agreement (RSA) – A contractual arrangement between a payer… #
Related terms: Outcomes‑based contract, managed entry. Example: A payment‑by‑results scheme for a gene therapy where reimbursement depends on patient survival at two years. Practical application: Reducing payer uncertainty while facilitating market entry. Challenges: Defining measurable outcomes, data collection infrastructure, and legal complexities.
Stakeholder Analysis – Systematic identification and assessment of indivi… #
Related terms: Influence mapping, interest‑power matrix. Example: A matrix categorizing patients, clinicians, insurers, and NGOs by level of interest and influence. Practical application: Prioritizing engagement efforts and tailoring messages. Challenges: Incomplete information, dynamic stakeholder positions, and resource constraints.
Strategic Communication – Planned dissemination of information to influen… #
Related terms: Messaging, media relations. Example: A campaign using infographics and testimonials to highlight the economic burden of untreated hypertension. Practical application: Shaping public opinion and building political pressure. Challenges: Message fatigue, misinformation, and media fragmentation.
Supply‑Side Economics – Economic theory emphasizing the role of producers… #
Related terms: Production function, incentive structures. Example: Arguing that tax incentives for R&D will lower long‑term drug costs. Practical application: Framing advocacy around fostering innovation ecosystems. Challenges: Quantifying long‑term benefits, addressing short‑term budget constraints, and reconciling with demand‑side concerns.
Technology Transfer – The process of moving scientific discoveries from r… #
Related terms: Licensing, commercialization. Example: Transferring a novel diagnostic assay to a biotech company for scaling. Practical application: Advocating for policies that support translational pathways. Challenges: Intellectual property negotiations, regulatory hurdles, and funding gaps.
Therapeutic Index – The ratio between the dose that produces a therapeuti… #
Related terms: Safety margin, dose‑response. Example: A high therapeutic index indicating a wide safety window for a new antihypertensive. Practical application: Using safety data to argue for favorable pricing. Challenges: Variability across patient subgroups and limited real‑world safety data.
Value‑Based Pricing (VBP) – A pricing approach that links the price of a… #
Related terms: Outcome‑based pricing, cost‑effectiveness. Example: Setting a price for a rare disease therapy based on its cost per QALY gained. Practical application: Aligning manufacturer incentives with payer willingness to pay. Challenges: Measuring value, negotiating metrics, and addressing equity concerns.
Value Proposition – A clear statement of the benefits, costs, and unique… #
Related terms: Positioning, benefit claim. Example: “Our device reduces hospital stays by 30 % while improving patient mobility.” Practical application: Crafting persuasive messages for payers, clinicians, and patients. Challenges: Substantiating claims with robust data and differentiating from competitors.
Variability Analysis – Examination of how changes in input parameters aff… #
Related terms: Sensitivity analysis, scenario testing. Example: Testing how different discount rates influence the incremental cost‑effectiveness ratio of a vaccine. Practical application: Demonstrating robustness of results to policymakers. Challenges: Selecting relevant ranges, interpreting complex results, and communicating uncertainty.
Virtual Advisory Board – An online panel of experts convened to provide s… #
Related terms: Expert panel, digital forum. Example: A virtual board of health economists, clinicians, and patient leaders discussing reimbursement pathways for gene therapies. Practical application: Gathering diverse insights quickly and cost‑effectively. Challenges: Ensuring balanced representation, managing digital fatigue, and protecting confidentiality.
World Health Organization (WHO) Guidelines – Internationally recognized r… #
Related terms: Global health policy, normative guidance. Example: WHO’s guideline endorsing universal access to antiretroviral therapy. Practical application: Citing WHO endorsement to strengthen national advocacy campaigns. Challenges: Adaptation to local contexts, timing of updates, and potential conflicts with domestic interests.
Health Equity Impact Assessment – Evaluation of how a policy or intervent… #
Related terms: Equity analysis, disparity assessment. Example: Assessing whether a new telehealth service will improve access for rural versus urban patients. Practical application: Integrating equity considerations into advocacy narratives. Challenges: Data disaggregation, measuring intangible outcomes, and addressing systemic barriers.
Pharmaceutical Benefit Scheme – A government program that subsidizes pres… #
Related terms: Drug subsidy, national formulary. Example: Australia’s Pharmaceutical Benefits Scheme (PBS) which determines reimbursement levels for listed drugs. Practical application: Targeting advocacy toward scheme listing criteria and price negotiations. Challenges: Stringent cost‑effectiveness thresholds, budget caps, and complex application processes.
Health Economics Education – Training programs designed to develop compet… #
Related terms: Professional certificate, curriculum. Example: A certificate course covering cost‑effectiveness, market access, and health policy advocacy. Practical application: Building a skilled workforce to support evidence‑based advocacy. Challenges: Balancing theory with practical skills, updating content to reflect evolving methodologies, and ensuring accessibility.
Health Policy Evaluation – Systematic assessment of the outcomes, efficie… #
Related terms: Program evaluation, impact assessment. Example: Evaluating the effect of a new reimbursement rule on drug utilization patterns. Practical application: Generating feedback loops for continuous improvement and advocacy refinement. Challenges: Attribution of outcomes, data lag, and stakeholder resistance to evaluation findings.
Health Outcomes Research – Study of the end results of health care practi… #
Related terms: Effectiveness research, epidemiology. Example: Research measuring mortality reduction after introduction of a novel vaccine. Practical application: Supplying robust outcome data to support policy change. Challenges: Longitudinal follow‑up, confounding variables, and translating findings into policy language.
Health System Strengthening – Efforts to improve the performance of healt… #
Related terms: System reform, capacity development. Example: Initiatives to enhance supply chain management for essential medicines. Practical application: Aligning advocacy with broader system‑level reforms to achieve sustainable impact. Challenges: Coordination across sectors, resource limitations, and political will.
Health Technology Lifecycle – The stages a health technology passes throu… #
Related terms: Product pipeline, diffusion curve. Example: Tracking a medical device from prototype to market saturation. Practical application: Timing advocacy interventions to coincide with critical lifecycle phases. Challenges: Forecasting adoption rates, managing legacy technologies, and anticipating regulatory changes.
Health Value Framework – A structured approach to assess the overall valu… #
Related terms: Multidimensional assessment, value matrix. Example: A framework that scores a therapy on efficacy, safety, cost, and patient preference. Practical application: Providing a holistic justification for market access. Challenges: Weighting criteria, achieving consensus, and data integration.
Impact Investing – Investment strategies that aim to generate measurable… #
Related terms: Social finance, ESG investing. Example: Venture funds targeting affordable diagnostics for low‑income settings. Practical application: Mobilizing alternative financing sources for health innovations. Challenges: Defining impact metrics, balancing profit expectations, and ensuring alignment with health system needs.
Incentive Alignment – Designing policies and contracts that encourage sta… #
Related terms: Pay‑for‑performance, value‑based contracts. Example: A reimbursement model that rewards hospitals for reducing readmission rates. Practical application: Fostering collaboration between providers, payers, and manufacturers. Challenges: Metric selection, data collection, and unintended consequences.
Institutional Review Board (IRB) – Committee that reviews and monitors re… #
Related terms: Ethics committee, research oversight. Example: IRB approval required for a real‑world study collecting patient health records. Practical application: Ensuring ethical compliance in data‑driven advocacy research. Challenges: Varying jurisdictional requirements, delays in approval, and balancing risk‑benefit considerations.
Legislative Process – The procedural steps through which a bill becomes l… #
Related terms: Lawmaking, parliamentary procedure. Example: Navigating the health committee stage to secure support for a chronic disease funding bill. Practical application: Timing advocacy outreach to coincide with key voting windows. Challenges: Political bargaining, agenda‑setting competition, and rapid policy shifts.
Market Segmentation – Division of a broader market into distinct groups b… #
Related terms: Target market, niche strategy. Example: Segmenting the market for a rare disease drug by high‑income versus middle‑income countries. Practical application: Tailoring advocacy messages to the priorities of each segment. Challenges: Data granularity, overlapping segments, and resource allocation.
Negotiated Access – Arrangements where payers and manufacturers agree on… #
Related terms: Early access, compassionate use. Example: A managed entry agreement allowing patients to receive a novel oncology drug while price negotiations continue. Practical application: Providing interim solutions to meet urgent patient needs. Challenges: Regulatory compliance, financial risk, and ensuring equitable access.
Outcome Measure – A quantifiable indicator used to assess the effect of a… #
Related terms: Endpoint, metric. Example: 5‑Year survival rate as an outcome measure for a cardiac surgery. Practical application: Selecting appropriate outcomes for economic evaluations and advocacy briefs. Challenges: Selecting clinically relevant measures, data collection burden, and cross‑study comparability.
Patient Advocacy Group (PAG) – An organization representing the interests… #
Related terms: Disease coalition, support network. Example: A rare‑disease PAG campaigning for faster drug approval pathways. Practical application: Leveraging patient voices to humanize economic arguments. Challenges: Limited resources, potential lack of technical expertise, and managing diverse patient expectations.
Pricing Transparency – Openness about the methodology, components, and ra… #
Related terms: Price disclosure, cost breakdown. Example: A manufacturer publishing the manufacturing cost, R&D investment, and margin for a new vaccine. Practical application: Facilitating fair negotiations and building public trust. Challenges: Competitive concerns, regulatory restrictions, and variability across markets.
Policy Alignment – Ensuring that advocacy objectives are consistent with… #
Related terms: Strategic fit, agenda setting. Example: Aligning a campaign for pediatric oncology funding with a national child health agenda. Practical application: Increasing the likelihood of policy adoption by demonstrating synergy. Challenges: Identifying overlapping priorities, avoiding mission drift, and navigating inter‑departmental coordination.
Policy Briefing Note – A short document prepared for senior officials tha… #
Related terms: Executive summary, memorandum. Example: A briefing note highlighting the economic case for expanding mental health services. Practical application: Delivering concise, decision‑oriented information to influence high‑level deliberations. Challenges: Balancing depth with brevity, anticipating counterarguments, and ensuring credibility.
Policy Window – A fleeting opportunity when political circumstances, publ… #
Related terms: Agenda‑setting, timing. Example: A surge in media coverage of drug shortages creating a window for reforming supply chain policies. Practical application: Mobilizing rapid advocacy actions to capitalize on the moment. Challenges: Unpredictability of windows, rapid mobilization needs, and sustaining momentum after the window closes.
Population Health Management – Strategies aimed at improving health outco… #
Related terms: Chronic disease management, care coordination. Example: A program that combines screening, lifestyle coaching, and medication adherence support for diabetes patients. Practical application: Demonstrating the cost‑saving potential of coordinated care to policymakers. Challenges: Data sharing across providers, patient engagement, and measuring long‑term outcomes.
Pricing Benchmark – A reference point used to compare the price of a heal… #
Related terms: Price comparator, market reference. Example: Using the average price of EU‑approved biosimilars as a benchmark for a new biologic. Practical application: Supporting arguments for price reductions or discounts. Challenges: Heterogeneity of comparators, exchange rate effects, and evolving market dynamics.
Quality‑Adjusted Life Year (QALY) – A metric that combines length of life… #
Related terms: Utility, health outcome. Example: A treatment that adds 0.5 QALYs per patient compared with standard care. Practical application: Serving as the common denominator in cost‑effectiveness analyses presented to payers. Challenges: Ethical debates over valuing life, cultural differences in utility weights, and methodological consistency.
Real‑Time Data Analytics – The use of up‑to‑date data streams to monitor… #
Related terms: Dashboards, big data. Example: A live dashboard tracking prescription volumes of a newly launched drug. Practical application: Providing timely evidence to adjust advocacy tactics. Challenges: Data integration, privacy concerns, and ensuring data accuracy.
Reimbursement Code – An identifier used by payers to classify and process… #
Related terms: Billing code, tariff. Example: A national coding system that assigns a unique code to a novel gene therapy for reimbursement purposes. Practical application: Ensuring accurate billing and facilitating reimbursement negotiations. Challenges: Code assignment delays, misclassification risks, and alignment with clinical practice.
Regulatory Pathway – The sequence of steps a health technology must under… #
Related terms: Approval process, dossier. Example: An accelerated approval pathway for breakthrough oncology drugs. Practical application: Informing advocacy on timelines and evidentiary requirements. Challenges: Differing international requirements, post‑approval commitments, and resource-intensive preparation.
Risk Assessment – Systematic identification and evaluation of potential h… #
Related terms: Safety analysis, threat evaluation. Example: Assessing the risk of antimicrobial resistance emerging from widespread antibiotic use. Practical application: Integrating risk mitigation strategies into advocacy proposals. Challenges: Uncertainty quantification, stakeholder disagreement on acceptable risk levels, and dynamic risk landscapes.
Stakeholder Mapping – Visual or tabular representation of key actors, the… #
Related terms: Influence diagram, power matrix. Example: A map showing ministries, insurers, patient groups, and industry players in the vaccine reimbursement process. Practical application: Directing resources toward high‑impact engagements. Challenges: Keeping the map current, capturing informal influencers, and avoiding oversimplification.
Strategic Partnership – Formal collaboration between organizations that c… #
Related terms: Joint venture, alliance. Example: A partnership between a pharmaceutical company and a patient advocacy coalition to develop a policy brief on rare disease funding. Practical application: Amplifying reach and credibility of advocacy messages. Challenges: Aligning goals, managing intellectual property, and ensuring equitable contribution.
Subsidy Policy – Government measures that reduce the price paid by consum… #
Related terms: Price reduction, reimbursement aid. Example: A subsidy program lowering out‑of‑pocket costs for insulin in low‑income populations. Practical application: Advocating for targeted subsidies to improve access. Challenges: Budget constraints, eligibility determination, and potential market distortions.
Supply Chain Resilience – The ability of the health product supply chain… #
Related terms: Logistics, inventory management. Example: Diversifying manufacturing sites to mitigate risks of single‑source dependency for a critical vaccine. Practical application: Arguing for policy measures that strengthen supply chain robustness. Challenges: Cost implications, regulatory harmonization, and coordination among multiple actors.
Technology Assessment Framework – Structured set of criteria and processe… #
Related terms: Assessment matrix, appraisal tool. Example: A national HTA agency employing a framework that includes clinical effectiveness, cost‑effectiveness, and ethical considerations. Practical application: Aligning advocacy evidence with the criteria used by decision‑makers. Challenges: Varying frameworks across jurisdictions, complexity of criteria weighting, and time‑intensive reviews.
Therapeutic Area – A specific field of medicine focusing on a set of rela… #
G., Oncology, cardiology). Related terms: Disease segment, clinical domain. Example: The oncology therapeutic area encompassing all cancer‑related interventions. Practical application: Targeting advocacy to the relevant specialist committees and payer groups. Challenges: Overlapping disease definitions, rapidly evolving treatment landscapes, and competition for limited resources.
Value of Information (VOI) Analysis – A method to quantify the benefit of… #
Related terms: Decision uncertainty, expected value of perfect information. Example: Calculating the monetary value of conducting a further trial to reduce uncertainty about a drug’s cost‑effectiveness. Practical application: Prioritizing research investments that will most improve decision quality. Challenges: Complex modeling, assumptions about future data, and translating monetary values into policy actions.
Value‑Based Reimbursement – Payment models that tie reimbursement levels… #
Related terms: Outcome‑based contracts, performance‑linked payment. Example: A contract where a payer reimburses a hospital only if a surgical device reduces post‑operative complications by a pre‑specified amount. Practical application: Aligning incentives for manufacturers and payers to focus on real‑world effectiveness. Challenges: Data collection infrastructure, defining appropriate outcomes, and negotiating risk allocation.
Virtual Clinical Trial – A research design that utilizes digital tools, r… #
Related terms: Decentralized trial, e‑clinical study. Example: A fully remote study evaluating the safety of a wearable cardiac monitor. Practical application: Generating rapid evidence to support policy arguments, especially in pandemic contexts. Challenges: Ensuring data integrity, regulatory acceptance, and participant adherence.
Willingness‑to‑Pay (WTP) – The maximum amount a decision‑maker is prepare… #
Related terms: Threshold, price ceiling. Example: A health system’s WTP of €30 000 per QALY guiding reimbursement decisions. Practical application: Framing cost‑effectiveness results relative to the system’s WTP to demonstrate affordability. Challenges: Variability across regions, political influences on WTP, and ethical debates over monetizing health.
Zero‑Sum Budgeting – An allocation approach where any increase in spendin… #
Related terms: Constrained budgeting, fiscal neutrality. Example: A health ministry requiring that funding for a new therapy be balanced by cuts to other programs. Practical application: Highlighting the need for efficient resource reallocation in advocacy proposals. Challenges: Political resistance to cuts, difficulty in quantifying trade‑offs, and potential impact on service delivery.
Adaptive Licensing – A regulatory approach that allows staged market entr… #
Related terms: Conditional approval, phased market entry. Example: Granting provisional approval for a gene therapy based on early efficacy data, with post‑marketing commitments. Practical application: Using adaptive pathways to accelerate patient access while managing uncertainty. Challenges: Ensuring robust post‑approval data, aligning stakeholder expectations, and maintaining regulatory oversight.
Analytic Hierarchy Process (AHP) – A structured decision‑making technique… #
Related terms: Multi‑criteria analysis, decision matrix. Example: Prioritizing health interventions based on cost, effectiveness, and equity using AHP. Practical application: Supporting transparent prioritization in policy advocacy. Challenges: Subjective weighting, stakeholder disagreement on criteria importance, and computational complexity.
Budgetary Impact Forecasting – Projection of future financial implication… #
Related terms: Financial modeling, fiscal projection. Example: Estimating the 5‑year budget impact of introducing a novel immunotherapy for melanoma. Practical application: Providing decision‑makers with forward‑looking cost information to inform funding allocations. Challenges: Assumptions about uptake, price volatility, and macro‑economic influences.
Cost‑of‑Illness Study – An analysis that quantifies the economic burden o… #
Related terms: Economic burden, disease cost analysis. Example: A study estimating the national cost of chronic obstructive pulmonary disease at €5 billion annually. Practical application: Establishing a compelling case for investment in preventive or therapeutic interventions. Challenges: Data completeness, attribution of costs, and variability across populations.
Decision‑Making Unit (DMU) – The group of individuals within an organizat… #
Related terms: Buying committee, procurement team.